This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)
C3_ENDOCRINE_NAS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
161 |
4. Check minimum number of eventsNone |
161 |
5. Include endpointsNone |
161 |
6. Filter based on genotype QC (FinnGen only) |
161 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 161 | 94 | 67 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 55.89 | 49.55 | 64.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
111
4.61
14.46
3.6
2.9
—
—
—
0
0
101
519
3.54
13.69
15.1
5.6
1.2
1.2
mmol/l
0.91
96
466
107
585
3.47
12.82
15.2
5.7
1.2
1.2
mmol/l
0.68
76
504
34
89
4.58
12.40
8.5
3.4
117.2
79.7
ng/l
0.79
28
77
14
15
10.13
11.83
1.3
1.3
—
—
—
0
0
12
20
6.40
7.01
2.9
1.4
—
—
—
0
0
99
1273
0.42
6.22
4.3
4.4
1.4
1.5
mmol/l
1.07
91
1175
104
1307
0.42
5.98
4.7
4.9
2.6
2.7
mmol/l
0.31
94
1211
94
1224
0.44
5.79
3.8
4.0
1.4
1.2
mmol/l
1.60
85
1118
20
63
3.48
5.53
8.2
10.1
96.0
93.1
%
2.57
20
63
102
1282
0.44
5.51
4.3
4.4
4.5
4.6
mmol/l
0.33
94
1192
8
5
16.72
5.47
2.1
1.2
56.8
62.2
nmol/l
—
8
5
19
61
3.40
5.10
10.3
5.6
24.5
25.3
mmol/l
0.46
19
61
7
5
14.54
4.62
2.6
1.2
21.0
21.8
ug/l
—
7
5
88
601
2.02
4.60
10.3
3.6
15.4
11.3
umol/l
0.32
81
555
75
491
1.99
4.36
6.4
3.7
34.8
35.8
g/l
0.67
69
457
76
521
1.87
3.69
5.5
3.9
—
—
—
0
0
15
51
3.14
3.68
1.7
1.3
21.8
20.7
iu/l
—
10
43
54
337
1.91
3.46
3.2
2.6
0.4
0.4
e6/l
0.18
47
229
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
27
3.88
3.41
1.8
1.6
0.4
0.4
u/ml
—
5
13
14
50
2.97
3.17
9.0
11.1
24.1
25.1
mmol/l
0.82
14
44
63
429
1.77
2.98
3.5
2.8
—
—
—
0
0
41
248
1.88
2.84
2.8
2.0
—
—
—
0
0
9
23
4.08
2.82
1.3
1.8
88.3
92.0
%
—
9
23
74
535
1.71
2.80
3.5
2.2
76.2
77.0
nmol/l
0.10
67
471
24
124
2.10
2.57
6.9
11.3
0.3
1.5
mmol/l
0.67
19
100
5
7
7.32
2.56
1.2
2.6
—
—
—
0
0
20
96
2.24
2.56
12.3
6.9
1.1
1.4
mmol/l
1.34
20
89
8
21
3.95
2.50
1.5
2.3
3.6
4.1
g/l
—
8
21
6
12
5.15
2.42
6.8
1.4
3.1
310.8
u/ml
—
6
12
114
946
1.70
2.41
14.3
4.8
88.8
75.8
u/l
1.35
108
861
110
1260
0.60
2.26
5.2
4.5
6.0
6.0
mmol/l
0.15
98
1148
5
9
5.69
2.23
1.8
1.7
—
—
—
0
0
86
678
1.58
2.13
17.8
5.9
4.3
4.3
e9/l
0.03
77
588
13
57
2.39
2.03
14.9
3.8
23.3
24.7
mmol/l
0.76
13
51
5
13
3.93
1.73
1.4
1.3
—
—
—
0
0
5
15
3.40
1.53
1.0
1.1
—
—
—
0
0
5
15
3.40
1.53
1.0
1.3
—
—
—
0
0
16
87
1.93
1.52
1.8
1.4
—
—
—
0
0
9
37
2.52
1.50
1.1
1.1
—
—
—
0
0
27
176
1.64
1.43
1.8
1.5
—
—
—
0
0
44
323
1.50
1.41
5.0
3.8
0.0
0.0
estimate
0.00
22
89
114
1004
1.46
1.38
7.8
3.8
15.5
14.7
pmol/l
2.35
109
905
0
41
0.00
1.33
0.0
1.3
—
—
—
0
0
14
79
1.85
1.21
1.1
1.2
58.4
118.7
iu/ml
—
8
30
36
262
1.48
1.20
2.1
1.8
537.7
26635951.8
pmol/l
0.50
28
214
129
1381
0.67
1.16
15.7
8.3
27.0
24.5
u/l
1.00
120
1318
7
30
2.39
1.14
1.0
1.2
—
—
—
0
0
35
261
1.44
1.03
1.5
1.7
1.8
1.1
mg/l
0.47
20
203
5
23
2.21
0.98
1.2
1.9
—
—
—
0
0
18
119
1.58
0.93
1.8
1.5
—
—
—
0
0
18
119
1.58
0.93
1.9
1.5
—
—
—
0
0
109
1186
0.75
0.90
6.4
6.2
41.1
40.5
mmol/mol
0.29
98
1108
8
46
1.78
0.84
1.0
1.2
—
—
—
0
0
17
243
0.66
0.82
1.4
1.7
—
—
—
0
0
8
47
1.74
0.82
1.0
1.2
—
—
—
0
0
7
123
0.55
0.82
2.3
2.5
4.8
6.2
ug/l
—
7
111
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
27
203
1.40
0.77
2.9
2.3
134.8
1.3
e6/l
0.47
12
104
73
823
0.79
0.72
3.3
3.2
—
—
—
0
0
5
26
1.95
0.71
1.4
3.1
—
—
—
0
0
9
58
1.58
0.71
14.1
2.5
1.3
1.3
%
—
9
58
71
621
1.26
0.70
4.5
3.5
0.0
0.0
estimate
0.00
23
95
25
195
1.33
0.59
2.8
2.5
0.8
4.2
e6/l
—
8
96
0
23
0.00
0.59
0.0
1.2
—
—
—
0
0
16
215
0.72
0.57
1.5
1.3
2.4
12.5
u/ml
—
5
87
6
37
1.65
0.56
3.7
1.1
42.7
38.5
g/l
—
6
31
31
252
1.29
0.55
2.4
1.7
1405.0
1107.9
nmol/l
0.60
20
195
6
100
0.58
0.53
1.7
1.6
—
—
—
0
0
9
64
1.43
0.52
1.7
1.4
—
—
—
0
0
65
579
1.21
0.51
4.2
2.6
173.0
107.5
ug/l
0.59
58
535
70
628
1.20
0.51
5.7
4.9
0.0
0.0
estimate
0.00
22
95
71
639
1.20
0.50
4.5
3.5
0.0
0.0
estimate
0.00
23
91
17
215
0.77
0.42
1.5
1.3
14.3
33.3
iu/ml
—
7
76
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.2
1.3
—
1.9
—
0
5
5
36
1.40
0.38
1.2
1.3
—
—
—
0
0
6
41
1.48
0.36
3.7
1.1
11.4
10.5
g/l
—
6
34
6
43
1.41
0.35
3.7
1.1
3.1
3.9
g/l
—
6
33
6
43
1.41
0.35
3.7
1.1
2.4
3.1
g/l
—
6
34
6
43
1.41
0.35
3.7
1.1
6.2
7.9
g/l
—
6
33
6
43
1.41
0.35
3.7
1.1
—
—
—
0
0
34
298
1.18
0.32
3.9
2.3
349.9
10038.4
umol/l
2.03
26
253
7
54
1.31
0.31
1.1
1.6
—
—
—
0
0
33
368
0.87
0.25
3.2
2.8
5895.6
1258.5
ng/l
0.44
28
307
6
83
0.71
0.24
1.0
1.0
—
—
—
0
0
37
335
1.14
0.23
1.6
1.7
1.4
1.3
mmol/l
0.30
27
283
115
1187
0.89
0.23
24.8
12.8
38.0
39.9
%
1.15
81
857
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
6
48
1.26
0.20
7.3
3.3
25.8
24.9
mmol/l
—
6
48
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
46
492
0.91
0.18
4.8
3.8
33.4
108.9
ng/l
0.53
37
338
17
194
0.86
0.18
1.1
1.4
—
—
—
0
0
12
141
0.84
0.17
1.8
2.2
—
—
—
0
0
13
150
0.85
0.15
8.9
6.6
—
—
—
0
0
9
81
1.12
0.15
5.4
2.6
5.4
5.1
kpa
—
9
73
119
1215
0.92
0.13
8.1
4.6
1.6
1.8
mu/l
1.08
110
1102
14
157
0.88
0.11
1.6
2.4
—
—
—
0
0
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
5
48
1.04
0.09
1.2
1.6
—
—
—
0
0
9
85
1.06
0.07
1.0
1.3
—
—
—
0
0
84
854
0.97
0.05
3.4
3.0
73.9
41.6
u/l
2.02
77
793
51
497
1.04
0.04
5.2
3.6
—
—
—
0
0
120
1210
0.97
0.03
25.3
10.2
79.2
80.6
ml/min/173m2
0.22
106
937
31
301
1.04
0.02
1.1
1.4
0.9
1.2
u/ml
—
7
76
127
1279
0.97
0.02
22.8
11.8
25.7
22.6
mg/l
0.51
114
976
53
539
0.98
0.02
2.0
1.9
92.3
92.9
pmol/l
0.04
33
270
20
196
1.02
0.00
3.8
2.6
0.7
0.8
ug/l
0.13
14
137
29
285
1.02
0.00
8.4
3.7
25.0
24.7
%
0.04
12
140
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
7
76
0.92
0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1603.0
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
6
61
0.98
0.00
2.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_ENDOCRINE_NAS_EXALLC – Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).